Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
. 13.
2021
Opportunities for cannabis in supportive care in cancer
2019
Identity
International Standard Serial Number (ISSN)
1758-8340
Electronic International Standard Serial Number (EISSN)
1758-8359
Other
journal abbreviation
THER ADV MED ONCOL